Nikon Small World Honors 51st Annual Photomicrography Competition
Winning image of a common agricultural pest reveals the beauty and complexity of insects often overlooked in daily life MELVILLE,...
DNA
Illumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights
At ASHG, an early access customer from the London Health Sciences Center Research Institute will demonstrate the power of the...
Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot
Illumina's up-and-coming constellation innovation delivers accuracy, speed, and ease of use in trial by GeneDx Constellation outperformed orthogonal methods in...
Quintara Biosciences Completes Acquisition of Laragen Sanger Sequencing Business, Strengthening Service Continuity and Strategic Expansion in Los Angeles
SAN FRANCISCO, Oct. 15, 2025 /PRNewswire/ -- Quintara Biosciences today announced that it has completed the acquisition of Laragen Sanger...
EpiSign Inc. Launches METRIC — A Cloud-Based Software Platform Transforming Global Access to Epigenomic Diagnostics
LONDON, ON, Oct. 15, 2025 /PRNewswire/ - EpiSign Inc. today announced the launch of METRIC, a next-generation software platform that...
Doug Brown, Founder of Black Book Research, to Deliver Keynote at openEHR’s EHRCON25 in Barcelona, Spain
EHRCON25, openEHR's flagship global conference on electronic health record innovation, will gather health IT leaders from across South America, Africa,...
Akari Therapeutics Announces $2.5 Million Registered Direct Offering
BOSTON and LONDON, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX) (the “Company”), an oncology biotechnology company...
Trinity Consultants Acquires Benchmark Risk Group
The acquisition strengthens Trinity's interdisciplinary team of science advisers experienced in evaluating human health risks from chemical, physical and biological...
Sampled and AutoGen Announce Partnership for Next-Gen Nucleic Acid Extraction and Multiomic Workflows
PISCATAWAY, N.J., Oct. 14, 2025 /PRNewswire/ -- Sampled, a fully integrated analytical laboratory and biorepository, has partnered with AutoGen to...
NextPlat Names Amanda L. Ferrio, Vice President of Accounting & Finance, as its New Chief Financial Officer
Internal Promotion Supports Ongoing Business Refocusing Efforts with Established Financial Operations Expertise HALLANDALE BEACH, Fla., Oct. 14, 2025 /PRNewswire/ --...
Telomir Pharmaceuticals Announces New Data Showing That Telomir-1 Kills Aggressive Pancreatic Cancer Cells, One of the Deadliest Forms of Cancer
Findings complement previously announced results in triple-negative breast cancer (TNBC) and prostate cancer models, highlighting Telomir-1's consistent impact on cancer...
IMUNON to Present Phase 3 Ovarian Cancer Study of IMNN-001 at ESMO Congress
Prestigious European Society for Medical Oncology Conference “trials-in-progress” session Pivotal OVATION 3 trial of its DNA-mediated immunotherapy in newly diagnosed...
4DMT to Participate in Chardan’s 9th Annual Genetic Medicines Conference
EMERYVILLE, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage...
SpyGlass Pharma’s Novel BIM-IOL System Demonstrated a Statistically Significant Reduction in Mean IOP at 24 Months
42% reduction in mean intraocular pressure (IOP) compared to baseline (p<0.0001)100% of patients were off all topical IOP-lowering medications at...
Predictive Oncology Announces Additions to Board and Leadership Team to Support Digital Asset Treasury Strategy
Appoints Shawn Matthews, CEO of DNA Holdings Venture, Inc., and Former CEO of Cantor Fitzgerald, to its Board of Directors...
Aprea Therapeutics Announces Presentations at EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeutics
DOYLESTOWN, Pa., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical...
Milestone Scientific Commits to Regaining NYSE American Compliance Following Notification
Notification has no immediate effect on the Company’s listing or day-to-day operationsROSELAND, N.J., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Milestone...
Aanastra Inc Announces Presentations of Preclinical Data at Upcoming Conferences in Support of its Lead Programs for Anti-CD19 In Vivo CAR-T (AAN-14x) and In vivo Rescue of P53 Mutations in Tumors (AAN-53x)
Greater than 90% depletion of B cells within 12 hours of a single dose of AAN-14xMultiple redosing of AAN-14x at...
BioCryst to Acquire Astria Therapeutics, Strengthening Presence in HAE, Transforming Growth Profile
– Deal to add navenibart, a late-stage and long-acting plasma kallikrein inhibitor, in Phase 3 clinical development, to BioCryst’s HAE...
Evaxion to present a breadth of data from phase 2 trial with AI-designed personalized cancer vaccine EVX-01 at the ESMO Congress 2025
Presentation will cover two-year clinical efficacy, immunogenicity and safety dataData will be presented at an oral session on October 17,...